API
< Back to situations

[ORGANIZATION]

Italian Medicines Agency

Featured in 15 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [IT] [US]

Italy influenza, COVID-19 and RSV vaccination rollout

29 clusters · 247 sources · last updated

Latest: Italy reports decline in influenza vaccination rates among elderly

The 2026-2027 seasonal vaccination campaign in Italy, targeting influenza, COVID-19, and Respiratory Syncytial Virus (RSV), is underway. The Ministry of Health launched a national communication campaign, ‘The vaccine: th

[ACTIVE] [HEALTH] [IT]

Italian healthcare systemic issues and pharmaceutical reform

9 clusters · 110 sources · last updated

Latest: Italy healthcare experts discuss pharmaceutical innovation and chronic disease management

Community initiatives in Italy continue to expand support for individuals living with Alzheimer’s and dementia through programs like ‘Intrecci di vite’ in Piedmont and ‘Il Mercato in-forma’ in Modena. However, systemic h

[ACTIVE] [HEALTH] [US] [IT] [GR]

FDA and EMA progress for Rasonque pancreatic cancer drug

47 clusters · 326 sources · last updated

Latest: Greece provides new pancreatic cancer drug to patients

On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R

[ACTIVE] [HEALTH] [GR] [BG] [CY]

MedSafetyWeek 2026 global campaign

2 clusters · 21 sources · last updated

Latest: MedSafetyWeek 2026 campaign launches to improve drug safety

The MedSafetyWeek 2026 global campaign, running from November 2 to November 8, is an initiative coordinated by the Uppsala Monitoring Centre and supported by the World Health Organization and the International Coalition

[ACTIVE] [HEALTH] [ES] [IT]

Vorasidenib clinical development and recognition

2 clusters · 13 sources · last updated

Latest: Prix Galien Italia 2026 honors pharmaceutical innovations

Clinical research presented at the European Association of Neuro-Oncology congress in Rome indicated that vorasidenib achieved disease control in 96% of patients with grade 2 gliomas. This study, conducted across seven h

[QUIET] [HEALTH] [IT]

Italian pharmaceutical regulatory updates

2 clusters · 2 sources · last updated

Latest: Italy updates pharmaceutical package inserts

The Italian Ministry of Health and the Italian Medicines Agency (AIFA) have issued new regulatory guidelines and updates concerning medication management and documentation. In mid-October 2026, the Ministry of Health es

[QUIET] [HEALTH] [IT] [GB]

Adrenaline nasal spray developments for anaphylaxis

3 clusters · 18 sources · last updated

Latest: Adrenaline nasal spray becomes available in Italy for anaphylactic shock

Developments regarding adrenaline nasal sprays as an alternative to traditional auto-injectors for treating anaphylaxis have emerged in Europe. In Italy, the Italian Medicines Agency (AIFA) has approved the spray for us

[QUIET] [HEALTH] [IT]

AIFA pharmaceutical innovation and evaluation discussions

2 clusters · 10 sources · last updated

Latest: AIFA President Nisticò discusses pharmaceutical innovation and drug authorization

The Italian Medicines Agency (AIFA) has initiated institutional dialogues focused on the value of pharmaceutical innovation and its impact on the Italian National Health Service. During a conference in Genoa, discussions

[QUIET] [HEALTH] [IT]

Italian pharmaceutical spending and supply chain stability

3 clusters · 38 sources · last updated

Latest: Italian pharmaceutical spending reaches €6.78 billion in Q1 2026

The Italian Medicines Agency (AIFA) has released reports detailing fiscal and structural challenges within the national pharmaceutical sector. Earlier monitoring from early 2026 revealed a significant spending deficit in